Background and Purpose-Little is known about factors that predispose older adults to poor recovery after a stroke. In this study, we sought to evaluate prestroke measures of frailty and related factors as markers of vulnerability to poor outcomes after ischemic stroke. Methods-In participants aged 65 to 99 years with incident ischemic strokes from the Cardiovascular Health Study, we evaluated the association of several risk factors (frailty, frailty components, C-reactive protein, interleukin-6, and cystatin C) assessed before stroke with stroke outcomes of survival, cognitive decline (≥5 points on Modified Mini-Mental State Examination), and activities of daily living decline (increase in limitations). Results-Among 717 participants with incident ischemic stroke with survival data, slow walking speed, low grip strength, and cystatin C were independently associated with shorter survival. Among participants <80 years of age, frailty and interleukin-6 were also associated with shorter survival. Among 509 participants with recovery data, slow walking speed, and low grip strength were associated with both cognitive and activities of daily living decline poststroke. C-reactive protein and interleukin-6 were associated with poststroke cognitive decline among men only. Frailty status was associated with activities of daily living decline among women only. Conclusions-Markers of physical function-walking speed and grip strength-were consistently associated with survival and recovery after ischemic stroke. Inflammation, kidney function, and frailty also seemed to be determinants of survival and recovery after an ischemic stroke. These markers of vulnerability may identify targets for differing pre and poststroke medical management and rehabilitation among older adults at risk of poor stroke outcomes. 
S
troke is the fifth most common cause of death and a leading cause of disability in the United States. 1 Among victims with stroke, older adults have a higher mortality rate and increased risk of disability, 2-5 but little is known about which factors contribute to an older individuals' increased vulnerability to adverse outcomes after a stroke. Some studies have examined the association of clinical factors assessed at or shortly after stroke with poststroke mortality and functional recovery. 3, 4, [6] [7] [8] [9] [10] However, the effect of prestroke characteristics on stroke outcomes has received less attention. Given that the number of incident strokes is expected to increase, with the majority of this increase occurring in individuals over the age of 75 years, 2 understanding what underlying factors portend higher mortality, disability, and poor quality of life after stroke are of critical interest.
Frailty is a geriatric syndrome, characterized by decreased reserve or resilience to stressors, attributed to cumulative multisystem decline. [11] [12] [13] Given that previous research has demonstrated that age is the strongest predictor of adverse stroke outcomes, we aimed to investigate the contributing role of frailty on outcomes among older adults. A stroke event is a significant stressor; therefore, we hypothesized that frailty would be an important determinant of poor recovery after stroke. In this study, we examined frailty and the frailty-associated risk factors for chronic inflammation and renal function as predictors of survival and cognitive and physical recovery after stroke. [14] [15] [16] These measures are powerful markers of the physiological aging process and are strongly associated with adverse outcomes. 13 For comparison, we also evaluated the importance of traditional measures of cardiovascular health. Although there is a preponderance of literature establishing the importance of frailty in older adults, this is the first study to look at the effect of frailty on recovery after stroke.
This study was conducted in the Cardiovascular Health Study, an observational cohort study. We focused exclusively on ischemic strokes because they are more common than hemorrhagic strokes among older adults. The purpose of this study was to evaluate candidate risk factors that may contribute to an older individuals' resilience, or ability to survive and recover, after a stroke.
Methods

Cardiovascular Health Study
The CHS (Cardiovascular Health Study) is a community-based cohort study of 5888 adults aged 65 years and older intended to study risk factors for cardiovascular disease, as detailed elsewhere. 17 Participants were recruited in 2 waves (1989-1990 and 1992-1993 ) from Medicare eligibility lists in Forsyth County, NC; Sacramento County, CA; Washington County, MD; and Pittsburgh, PA. Approximately 57.3% of eligible participants were enrolled in CHS. 18 Potential disease events were identified through semiannual phone calls, hospital discharge report review, and Centers for Medicaid & Medicare Services data. Deaths were identified by obituary review, medical records, death certificates, National Death Index and household contacts. A group of experts adjudicated all incident cardiovascular and cerebrovascular events and causes of death. CHS has achieved a 100% complete follow-up of mortality status. 19 Data used for this analysis were censored on June 30, 2011. This study was determined to be exempt by the Oregon State University Institutional Review Board.
Risk Factors
Frailty was assessed according to the Fried criteria, an established measure of frailty originally developed in CHS. 13 The Fried frailty definition includes: unintentional weight loss, exhaustion, low physical activity, slow walking speed, and low grip strength. 13 Participants who met 1 or 2 of the frailty components were considered "prefrail" and participants who met 3 or more were considered "frail." Slow walking speed was assessed as the slowest quintile at baseline, based on time to walk 15′, adjusted for sex and standing height. 13 Low grip strength, measured in the dominant hand, was also based on the lowest quintile, after accounting for sex and body mass index. 13 Low physical activity was defined as the lowest quintile, by sex, of kilocalories of weekly physical activity. Thresholds for slow walking speed, low grip strength, low physical activity defined at baseline were used for the assessment of these measures at later assessments. Exhaustion was based on the self-report of 2 questions in the Center for Epidemiologic Studies Depression scale. Unintentional weight loss was defined as self-reported weight loss of >10 lbs not because of exercise nor diet. Individual criteria of frailty were included in frailty assessment as well as separate risk factors of interest.
Stored serum samples were used to assess concentrations of biomarkers of inflammation and renal function. C-reactive protein (CRP), an acute phase reactant protein, and interleukin-6 (IL-6), an inflammatory activating cytokine, were measured using high-sensitivity ELISA (RD Systems, Minneapolis, MN; Roche Diagnostics, Indianapolis, IN). Cystatin C, a marker of kidney function, was measured by particle-enhanced immunoephelometry (BNII nephelometer) (Seimens Healthcare Diagnostics, Deerfield, IL; N Latex Cystatin C).
For comparison, we included cholesterol and blood pressure as traditional cardiovascular risk factors. Total cholesterol was measured in overnight fasting blood samples. Systolic and diastolic blood pressures were assessed in seated participants after 5 minutes of rest; 3 readings were obtained and the average of the last 2 readings was recorded.
Risk factor measures from baseline and years 3, 7, and 16 were used in analyses (except frailty and low physical activity which were only available at baseline, years 3, and 16). For each candidate risk factor analysis, only stroke events with candidate risk factor measurements obtained ≤5 years before incident stroke events were included, which accounts for variation in sample size across analyses. The mean time from risk factor measurement to incident stroke was 2.2 years.
Stroke Outcomes
Survival time was defined as length of time in days from stroke event until death. When available, hours from the time of stroke until death was included. For 28 fatal strokes with survival time of less than 1 day and for which hours of survival were not recorded, a survival time 0.1 days was assigned.
We allowed 1 year for potential recovery between stroke and assessment of cognitive function and activities of daily living (ADL) score as previous research has suggested that that recovery of walking speed is minimal after the first 11 weeks and the majority of recovery for patients with stroke occurs within the first 6 months. 20 The mean time from stroke to recovery assessment was 1.6 years. ADL recovery was defined by examining the difference between pre-and poststroke ADL limitation assessment. Rated difficulty in 6 different ADLs was assessed through questionnaires; a limitation was defined as difficulty or inability to perform one or more ADL (bathing, eating, dressing, using the toilet, getting out of bed or chair, and walking around home). Participants who had an increase of 1 or more limitations between pre and post stroke ADL assessment were considered to have failed recovery in ADLs (ADL decline) poststroke.
Statistical Analyses
We described the characteristics of 3 groups: CHS participants with incident (first) ischemic stroke occurring during the CHS, CHS participants with incident ischemic stroke who are eligible for survival analyses, and CHS participants with incident ischemic stroke who are eligible for recovery analyses. For characteristics with multiple measurements, we utilized the most recently obtained assessment that occurred before stroke.
We assessed the association between the potential risk factors measured before the stroke and survival time poststroke using Cox proportional hazard models. Logistic models were used to assess the association of potential risk factors with both measures of recovery. In recovery analyses, the prefrail and frail categories were combined because of sample size. Separate models were run to analyze each candidate risk factor, adjusted for time between risk factor assessment and the stroke event. Proportional hazards assumption was assessed for all the Cox models presented based on the Schoenfeld residuals. 21 Potential confounders, selected a priori, included in adjusted analyses were age at the time of stroke, ischemic stroke subtype, stroke location, race, sex, and education. The most recent but before stroke assessments of smoking status, alcohol consumption, living arrangement, atrial fibrillation, coronary heart disease, heart failure, diabetes mellitus, depressive symptoms (Center for Epidemiologic Studies Depression >12), low cognitive function (Modified Mini-Mental State Examination score of <80), body mass index, anticoagulant use, and antihypertensive medication use were also included in adjusted models. Effect modification of risk factors by age at the time of stroke, sex, race, and time between risk factor measurement and stroke was also assessed. Stratum-specific estimates were presented if the P value for interaction was <0.05 in unadjusted or adjusted analyses.
Additional details about the CHS, stroke event assessment, study populations, and recovery measures are included in the Methods in the online-only Data Supplement. 
Results
Among 5639 participants without stroke at baseline, 894 incident ischemic strokes occurred during 22 years of follow-up. To accommodate the timing of the risk factor measures, our sample included 717 participants eligible for the survival analysis and 509 eligible for the recovery analysis. (Figure in the online-only Data Supplement) The median survival time after stroke was 3.3 years for the stroke survival population and 3.8 years for the stroke recovery population. Of the 717 participants eligible for the survival analysis, 645 died and 72 were censored. Table 1 details the characteristics of all participants with ischemic stroke as well as of the stroke survival and stroke recovery eligible study populations. In separate models, cystatin C was associated with shorter survival after stroke in unadjusted and adjusted models ( Table 2) . Among participants younger than 80 years of age, frailty and IL-6 were associated with shorter survival after stroke, although these associations were not observed among older participants: adjusted P values for interaction were 0.05 for prefrail, 0.06 for frail and 0.03 for IL-6. Among participants 80 and older only, higher total cholesterol was associated with longer survival after stroke before adjustment for potential confounders (unadjusted P value for interaction=0.02). Sex, race, and time since risk factor measurement did not modify the effect of any of the candidate risk factors on poststroke survival time: all P values for interaction >0.05.
In unadjusted models, frailty status and cystatin C were significantly associated with cognitive decline after stroke, although these associations were modestly attenuated and no longer reached statistical significance in an adjusted model. (Table 3 ) Among men only, inflammatory markers CRP and IL-6 were independently associated with cognitive decline: adjusted P values for interaction were 0.01 for CRP and 0.04 for IL-6. Age, race, and time since risk factor measurement did not modify the effect of any of the candidate risk factors on cognitive decline after adjustment and accounting for the sex interaction. Results were similar in sensitivity analyses that assumed participants with missing cognitive measures had cognitive decline or no cognitive decline (Tables I and  II in the online-only Data Supplement), although cystatin C emerged as a statistically significant risk factor in analyses imputing missing cognitive measures as no cognitive decline
In unadjusted models, IL-6 and cystatin C were significantly associated with poststroke ADL decline, although these associations were modestly attenuated and not statistically significant after adjustment. (Table 4 ) In women, prefrail or frail status were associated with poststroke ADL decline before and after adjustment. Age, race, and time since risk factor measurement did not modify the effect of any of the candidate risk factors on ADL decline after adjustment and 
Stroke
July 2017
accounting for effect modification by sex. Results were similar in sensitivity analyses that imputed missing ADL measures as ADL decline or no ADL decline (Tables III and IV in the online-only Data Supplement), although higher CRP and IL-6 emerged as statistically significant risk factors analyses imputing missing ADL measures as ADL decline. Among the frailty components, slow walking speed and grip strength were consistently associated with the outcomes of shorter survival, cognitive decline, and increased ADL limitation. (Table 5 ) Low physical activity was associated with shorter survival only among participants aged <80 years (adjusted P value for age interaction=0.009) and with ADL decline only among women (unadjusted P value for sex interaction=0.04). Unintentional weight loss was borderline statistically significantly associated with shorter survival, and exhaustion was modestly associated with ADL decline.
Discussion
This the first study to evaluate the association of frailty and related clinical characteristics with the clinically relevant adverse outcomes of shorter survival and poor recovery poststroke. Pre-stroke frailty, inflammation, and renal function were associated with ischemic stroke outcomes of survival and recovery. The low physical function components of frailty, measured by walking speed and grip strength, were the most consistent determinant of shorter survival and lack of poststroke recovery in cognition and ADL. The associations of inflammation, renal function, and frailty with recovery after stroke varied by the outcome measured and by sex and age. Established cardiovascular risk factors -elevated systolic and diastolic blood pressures and total cholesterolwere not independently associated with survival or recovery in cognition or ADL. Because of the long follow-up and large sample size of incident ischemic strokes, we were able to assess several relevant risk factors while simultaneously adjusting for previously established predictors of adverse stroke outcomes. Taken together, our findings support our hypothesis that frailty factors, including the frailty syndrome and physical function, as well as the related pathways of chronic inflammation and renal function may indicate vulnerability to poor recovery after ischemic stroke. These factors could help identify those individuals at the greatest risk for poor stroke outcomes, or be evaluated as potential clinical targets for intervention.
Previous studies have shown that age, 22 sex, 4,23 smoking status, 24 living arrangement, 6 ,10 history of heart failure, 22 are associated with stroke severity, fatality, functional status, or some combination of these outcomes.
The majority of these studies assessed risk factors at the time of stroke. 3, 4, [6] [7] [8] [9] [10] In a previous study of the CHS cohort, stroke subtype, older age and slow walking speed were associated with stroke fatality among incident strokes. 22 A subsequent *Adjusted for time between risk factor assessment and stroke. †Adjusted for time between risk factor assessment and stroke, ischemic stroke subtype, stroke location, race, sex, education attainment, smoking status, alcohol consumption, living alone status, atrial fibrillation, coronary heart disease, congestive heart failure, diabetes mellitus, depression (CES-D>12), low cognitive function (3MSE<80), BMI, anticoagulant use, and antihypertensive medication use.
‡n in each analysis. §P value for interactions. ‖Per doubling in concentration. #Per 10 mm Hg. ¶Per 10 mg/dL. *Adjusted for time between risk factor assessment and stroke. †Adjusted for time between risk factor assessment and stroke, ischemic stroke subtype, stroke location, race, sex, education attainment, smoking status, alcohol consumption, living alone status, atrial fibrillation, coronary heart disease, congestive heart failure, diabetes mellitus, depression (CES-D>12), low cognitive function (3MSE<80), BMI, anticoagulant use, and antihypertensive medication use.
‡n in each analysis. §P value for interactions. ‖per doubling in concentration. #per 10 mm Hg. ¶per 10 mg/dL.
CHS study of exclusively ischemic stroke demonstrated that age, sex, and stroke subtype were associated with death after stroke and participation in CHS study visits after stroke. 24 In the same study, diabetes mellitus, smoking status, and total cholesterol were associated with poststroke outcomes of recurrent stroke and coronary heart disease.
We found a differential association of some prestroke risk factors and outcomes by age and sex; associations of frailty and IL-6 with poststroke survival were significantly attenuated at older age. This might be attributable to increasing heterogeneity among the oldest old, a difference in phenotype of resilience to ischemic stroke among very old individuals, or chance. For poststroke recovery, we observed effect modification by sex, consistent with previous studies that have reported that impairment and institutionalization after stroke differ by sex. 23, 26 Inflammatory biomarkers, CRP and IL-6, were only associated with poststroke cognitive decline in men. In addition, frailty was only associated with poststroke cognitive decline, and ADL decline in women. Our findings suggest that not only do rates of recovery differ by sex but also the profile of underlying factors that influence stroke recovery may differ between men and women.
Well-established cardiovascular risk factors for high blood pressure and elevated total cholesterol were not associated with an increased risk of death, cognitive decline, or ADL decline poststroke. Although high blood pressure and high cholesterol may increase the risk of ischemic stroke, these factors do not seem to increase the risk of adverse outcomes after stroke. Interestingly, we found that total cholesterol appeared modestly protective for poststroke survival among participants aged 80 years and older in unadjusted analyses. Similar findings between total cholesterol and function outcomes poststroke have been observed previously, 8 and other research suggests that a low cholesterol may be a marker of frailty and poor nutritional status in older age. *Adjusted for time between risk factor assessment and stroke. †Adjusted for time between risk factor assessment and stroke, ischemic stroke subtype, stroke location, race, sex, education attainment, smoking status, alcohol consumption, living alone status, atrial fibrillation, coronary heart disease, congestive heart failure, diabetes mellitus, depression (CES-D>12), low cognitive function (3MSE<80), BMI, anticoagulant use, and anti-hypertensive medication use.
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‡n in each analysis. §P value for interactions.
The associations of frailty, physical function, chronic inflammation and renal function with poor stroke outcomes suggest that these factors may indicate decreased physiological resilience to ischemic stroke events. These associations may also relate to stroke severity and medical and rehabilitation therapy after stroke. Multiple previous studies demonstrated that stroke severity, commonly assessed by National Institute of Health stroke scale, is significantly associated with adverse stroke outcomes. 3, 7 Without scores on this scale, we were not able to address the effect of stroke severity as a potential confounder, effect modifier or mediator on the relationship between prestroke risk factors and poststroke outcomes. We attempted to address potential confounding by stroke severity by adjusting for variables that were previously demonstrated to be associated with stroke severity in our adjusted analyses, including atrial fibrillation, previous heart failure, and low cognitive function before stroke. 10 We were also unable to adjust for aggressiveness of care after stroke, but attempted to address this issue by adjusting for living arrangement before stroke, as well as sex and age, which are known to contribute to treatment after stroke. 23, 24 Another limitation to our study is missing data in both the risk factors presented and in stroke recovery outcomes. Missing data on the risk factors may have limited our sample size and power to detect associations. Missing data on stroke recovery were substantial as some participants did not return to follow-up after stroke and may have introduced selection bias into our study design. To address this issue, we ran a sensitivity analyses on the participants who survived beyond 1 year but did not return for study follow-up. 28 Findings from these analyses were largely consistent with our primary analysis. Missing data on recovery may have also hindered our power to detect significant associations after adjustment.
Although several studies previously addressed risk factors for stroke incidence, few have considered what factors may predispose stroke victims to adverse outcomes. This study represents the largest study we are aware of on the association between inflammatory, renal, cardiovascular, physical functioning, and frailty measures assessed before stroke with clinically relevant stroke outcomes of duration of survival, cognitive decline, and ADL decline. Prestroke physical function and renal function were strong predictors of ischemic stroke outcomes in older adults and may serve as markers of resilience or vulnerability to ischemic stroke. Markers of frailty and inflammation were associated with shorter survival, but performed differently between men and women as markers of poststroke recovery. We did not attempt to address the underlying mechanism for associations of these risk factors with stroke outcomes, namely whether risk factors influenced the severity of the stroke, ability to recovery after stroke, or assignment of treatment post stroke. Regardless of whether identified risk factors affect stroke severity or ability to recover, modifying these risk factors has the possibility to improve stroke outcomes if the associations demonstrated in this study are proven causal. Further understanding of the factors that lead to increased vulnerability to poor cerebrovascular outcomes may help address how to improve resilience to potentially fatal and debilitating stroke events and optimize prevention and post stroke care.
